POTASSIUM Drug Patent Profile

Which patents cover Potassium, and when can generic versions of Potassium launch?

Potassium is a drug marketed by Exela Pharma, Fresenius Kabi Usa, Hospira, Hexcel, Actavis Labs Fl Inc, Adare Pharms Inc, Amneal Pharms, Chartwell Molecular, Endo Operations, Glenmark Pharms Ltd, Granules, Lupin Ltd, Nesher Pharms, Novel Labs Inc, Padagis Us, Prinston Inc, Strides Pharma, Teva, Tris Pharma Inc, Zydus Pharms, Ajenat Pharms, Amneal, Epic Pharma Llc, Genus, Novitium Pharma, Rubicon, Abraxis Pharm, B Braun, Baxter Hlthcare, Gd Searle Llc, Intl Medication, Lilly, Luitpold, Miles, Nexus Pharms, Pharma Serve Ny, Watson Labs, Anda Repository, Apotex, Genus Lifesciences, Pharm Assoc, Sciegen Pharms Inc, Wes Pharma Inc, Ascent Pharms Inc, Aurobindo Pharma, Aurobindo Pharma Ltd, Breckenridge, Chartwell Rx, Copley Pharm, Guangzhou Novaken, Macleods Pharms Ltd, Mylan, Rising, Schering, Sigmapharm Labs Llc, Twi Pharms, Yichang Humanwell, Icu Medical Inc, Nexus, Ut Sw Medctr, Ani Pharms, Bionpharma, Hibrow Hlthcare, Teva Pharms Usa Inc, Torrent, Mission Pharmacal, Roxane, Am Regent, Cipla, Cmp Dev Llc, and Somerset Theraps Llc. and is included in one hundred and fifty-five NDAs. There is one patent protecting this drug.

The generic ingredient in POTASSIUM is potassium phosphate, dibasic; potassium phosphate, monobasic. There are two hundred and forty drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the potassium phosphate, dibasic; potassium phosphate, monobasic profile page.

DrugPatentWatch^® Generic Entry Outlook for Potassium

Annual sales in 2021 were $9mm indicating the motivation for generic entry (peak sales were $76mm in 2019).

Indicators of Generic Entry

Summary for POTASSIUM

US Patents:	0
Applicants:	71
NDAs:	155
Drug Prices:	Drug price information for POTASSIUM
Drug Sales Revenues:	Drug sales revenues for POTASSIUM
DailyMed Link:	POTASSIUM at DailyMed

See drug prices for POTASSIUM

See drug sales revenues for POTASSIUM

US Patents and Regulatory Information for POTASSIUM

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lilly	POTASSIUM CHLORIDE	potassium chloride	INJECTABLE;INJECTION	007865-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Baxter Hlthcare	POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9%	potassium chloride; sodium chloride	INJECTABLE;INJECTION	017648-001	Approved Prior to Jan 1, 1982	AP	RX	Yes	Yes
Icu Medical Inc	POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	dextrose; potassium chloride; sodium chloride	INJECTABLE;INJECTION	018876-007	Mar 28, 1988		DISCN	No	No
Icu Medical Inc	POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	dextrose; potassium chloride; sodium chloride	INJECTABLE;INJECTION	019691-003	Mar 24, 1988		DISCN	Yes	No